Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin.

@article{Zheng2012ReprogrammingOH,
  title={Reprogramming of human fibroblasts into multipotent cells with a single ECM proteoglycan, fibromodulin.},
  author={Zhong Zheng and Jia Jian and Xinli Zhang and Janette N. Zara and Wei Yin and Michael F. Chiang and Yi Liu and Joyce Z. Wang and Shen Pang and Kang Ting and Chia Soo},
  journal={Biomaterials},
  year={2012},
  volume={33 24},
  pages={
          5821-31
        }
}
View on PubMed
cirm.ca.gov
56 Citations
Highly Influential Citations
1
Background Citations
19
Methods Citations
3
Results Citations
2

Figures and Tables from this paper

56 Citations

CDKN2B upregulation prevents teratoma formation in multipotent fibromodulin-reprogrammed cells.

A novel, protein-based reprogramming method that does not require genome integration or oncogene activation to yield multipotent fibromodulin (FMOD)-reprogrammed (FReP) cells from dermal fibroblasts is established and it is shown that the decreased tumorigenicity of FReP cells was directly related to an upregulation of cyclin-dependent kinase inhibitor 2B (CDKN2B) expression during the FMOD reprograming process.

Fibromodulin reprogrammed cells: A novel cell source for bone regeneration.

Generation of pluripotent stem cells without the use of genetic material

What types of small chemical or large (protein) molecules could be used to replace the viral transduction of genes and/or genetic reprogramming to obtain human iPSCs are discussed.

Brief Azacytidine Step Allows The Conversion of Suspension Human Fibroblasts into Neural Progenitor-Like Cells

This work provides a simple way to induce neural progenitor-like cells from human fibroblasts without genetic manipulation by changing physicochemical culture properties from monolayer culture into a suspension in the presence of a chemical DNA methyltransferase inhibitor agent, Azacytidine.

Targeting cell plasticity for regeneration: from in vitro to in vivo reprogramming.

Pluripotency maintenance of amniotic fluid-derived stem cells cultured on biomaterials.

Surprisingly, hAFSCs that showed higher pluripotency on PVA hydrogels grafted with oligopeptides derived from fibronectin and vitronECTin also expressed higher levels of early differentiation markers for three germ layers in expansion medium, suggesting that hAF SCs are heterogeneous and that this population contains highly pluripotent stem cells and stem cells that can be easily differentiated.

Current Methods for Inducing Pluripotency in Somatic Cells

An overview on current reprogramming protocols is provided, discusses their pros and cons and future challenges to provide safe and transgene‐free iPSCs.

Generation of pluripotent stem cells via protein transduction.

An overview of the key processes and mechanism involved in protein-based somatic cell reprogramming is provided, and some promising methods for increasing its efficiency and future challenges are discussed.

Photopolymerizable hydrogel encapsulated fibromodulin-reprogrammed cells for muscle regeneration.

The photopolymerizable methacrylate glycol chitosan (MeGC)/type I collagen (ColI)-hydrogel provides a desirable microenvironment for encapsulated FReP cells survival, spreading, extension, and formation of myotubes in the hydrogel three-dimensionally in vitro, without undesired osteogenic, chondrogenic, or tenogenic differentiation.

Cardiomyocyte generation from somatic sources - current status and future directions.

...

References

SHOWING 1-10 OF 84 REFERENCES

Transient in vitro epigenetic reprogramming of skin fibroblasts into multipotent cells.

Generation of human induced pluripotent stem cells from dermal fibroblasts

Methods to use dermal fibroblasts easily obtained from an individual human to generate human induced pluripotent stem (iPS) cells by ectopic expression of the defined transcription factors KLF4, OCT4, SOX2, and C-MYC are described.

Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2

Valproic acid (VPA), a histone deacetylase inhibitor, enables reprogramming of primary human fibroblasts with only two factors, Oct4 and Sox2, without the need for the oncogenes c-Myc or Klf4, and supports the possibility of reprograming through purely chemical means.

Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts

A modified protocol for the generation of iPS cells that does not require the Myc retrovirus is described and, with this protocol, significantly fewer non-iPS background cells are obtained, and theiPS cells generated were consistently of high quality.

Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors

Induced Pluripotent Stem Cells Generated Without Viral Integration

This work generated mouse induced pluripotent stem cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c-Myc, providing strong evidence that insertional mutagenesis is not required for in vitro reprogramming.

Multilineage cells from human adipose tissue: implications for cell-based therapies.

The data support the hypothesis that a human lipoaspirate contains multipotent cells and may represent an alternative stem cell source to bone marrow-derived MSCs.

Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells

Nanog Overcomes Reprogramming Barriers and Induces Pluripotency in Minimal Conditions

Isolation of human iPS cells using EOS lentiviral vectors to select for pluripotency

The first selection system for the isolation of human iPS cells is reported, and the EOS (Early Transposon promoter and Oct-4 (Pou5f1 and Sox2 enhancers) lentiviral vector is developed to specifically express in mouse and human embryonic stem cells but not in primary fibroblasts.
...